TRANSITION THERAPEUTICS INC. (Existing under the Business Corporations Act (Ontario)) Common Share Purchase WarrantsWarrant Agreement • July 2nd, 2014 • Schuler Jack W • Medicinal chemicals & botanical products • Ontario
SUBSCRIPTION AGREEMENT FOR UNITSSubscription Agreement • July 2nd, 2014 • Schuler Jack W • Medicinal chemicals & botanical products • Ontario
The undersigned (hereinafter referred to as the Subscriber) hereby irrevocably subscribes for and agrees to purchase the number of units of the Corporation (Units) set forth below for the aggregate subscription price set forth below (the Aggregate Subscription Price), representing a subscription price of US$5.32 per Unit, upon and subject to the terms and conditions set forth in “Terms and Conditions of Subscription for Units of Transition Therapeutics” attached hereto (together with the face pages and the attached Exhibits, the Subscription Agreement). Each Unit consists of (i) one common share in the capital of the Corporation (a Common Share) and (ii) 0.61 Common Share purchase warrant with a purchase price of US$7.10 per whole Warrant (a Warrant), with each whole Warrant entitling the holder thereof to purchase one Common Share for a period of twenty four months from the Closing Date (as defined herein).
Joint Filing AgreementJoint Filing Agreement • July 2nd, 2014 • Schuler Jack W • Medicinal chemicals & botanical products
This Joint Filing Agreement is entered into as of July 1, 2014, by the undersigned, who hereby agree that the Statement on Amendment No. 2 to Schedule 13D in respect of the common shares ofTransition Therapeutics Inc. is, and any amendment subsequently signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
